531569 logo

Sanjivani Paranteral Limited Stock Price

BSE:531569 Community·₹2.6b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

531569 Share Price Performance

₹0
-337.10 (-100.00%)
₹0
-337.10 (-100.00%)
Price ₹0

531569 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with very low risk.

2 Risks
1 Reward

Sanjivani Paranteral Limited Key Details

₹689.2m

Revenue

₹416.8m

Cost of Revenue

₹272.4m

Gross Profit

₹197.8m

Other Expenses

₹74.6m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
6.07
39.52%
10.82%
19.7%
View Full Analysis

About 531569

Founded
1994
Employees
40
CEO
Ashwani Khemka
WebsiteView website
www.sanjivani.co.in

Sanjivani Paranteral Limited operates as a pharmaceutical company in India. The company manufactures pharmaceutical products in the form of oral solids, small volume parenteral, and sterile powder formulations for various therapeutic areas, including central nervous system, cardiovascular system, antibiotics, gastroenterological, anti-diabetics, and anti-allergic. It also offers soft gels, such as multivitamins; topicals comprising corticosteroids, antiseptics, NSAIDs, and anti-bacterial; nasal sprays; liquid and dry powder injections covering antibiotics, anti-emetic, NSAID and analgesic, antimalarial, and proton pump inhibitor and H2 receptor antagonist; capsules and tablets, including antibiotic, antifungal, anticonvulsant, multivitamins, and NSAID and analgesic; dry syrups; and ear/eye drops. In addition, the company exports its products. Sanjivani Paranteral Limited was incorporated in 1994 and is headquartered in Mumbai, India.

Recent 531569 News & Updates

Recent updates

No updates